aluates Reports

$ 0.0

Automative

Global Statin Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-14E11305

Global Statin Market Research Report 2022

BUY CHAPTERS

Global Statin Market Research Report 2025

Code: QYRE-Auto-14E11305

Report

September 2025

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Merck

Pfizer Inc

Daiichi Sankyo

Chia Tai Tianqing

Zhejiang Jingxin Pharmaceutical

Hanhui Pharmaceutical

Shanghai Shyndec Pharmaceutical

Livzon Pharmaceutical

North China Pharmaceutical

Novartis

Beijing Jialin Pharmaceutical

Henan Topfond Pharmaceutical

China Resources Double Crane Pharmaceutical

Wanbang Biopharmaceuticals

Huizhi

LUNAN BETTER

Statin Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Statin Market

The global market for Statin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Statin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Statin.

The Statin market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Statin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Statin companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Statin Market Report

Report Metric	Details
Report Name	Statin Market
CAGR	5%
Segment by Type	Astrovastatin Rosuvastatin Pitavastatin Others
Segment by Application	Cardiovascular Disorders Obesity Inflammatory Disorders Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AstraZeneca, Merck, Huizhi, Daiichi Sankyo, LUNAN BETTER, CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Hanhui Pharmaceutical, Shanghai Shyndec Pharmaceutical, Livzon Pharmaceutical, North China Pharmaceutical, Novartis, Beijing Jialin Pharmaceutical, Henan Topfond Pharmaceutical, China Resources Double-Crane Pharmaceutical, Wanbang Biopharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Statin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Statin Market report?

Ans: The main players in the Statin Market are Pfizer, AstraZeneca, Merck, Huizhi, Daiichi Sankyo, LUNAN BETTER, CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Hanhui Pharmaceutical, Shanghai Shyndec Pharmaceutical, Livzon Pharmaceutical, North China Pharmaceutical, Novartis, Beijing Jialin Pharmaceutical, Henan Topfond Pharmaceutical, China Resources Double-Crane Pharmaceutical, Wanbang Biopharmaceuticals

What are the Application segmentation covered in the Statin Market report?

Ans: The Applications covered in the Statin Market report are Cardiovascular Disorders, Obesity, Inflammatory Disorders, Others

What are the Type segmentation covered in the Statin Market report?

Ans: The Types covered in the Statin Market report are Astrovastatin, Rosuvastatin, Pitavastatin, Others

Recommended Reports

Cardiovascular Drugs

Pharmaceutical Services

Chronic Disease Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Statin Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Astrovastatin

1.2.3 Rosuvastatin

1.2.4 Pitavastatin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Statin Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cardiovascular Disorders

1.3.3 Obesity

1.3.4 Inflammatory Disorders

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Statin Market Perspective (2020-2031)

2.2 Global Statin Growth Trends by Region

2.2.1 Global Statin Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Statin Historic Market Size by Region (2020-2025)

2.2.3 Statin Forecasted Market Size by Region (2026-2031)

2.3 Statin Market Dynamics

2.3.1 Statin Industry Trends

2.3.2 Statin Market Drivers

2.3.3 Statin Market Challenges

2.3.4 Statin Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Statin Players by Revenue

3.1.1 Global Top Statin Players by Revenue (2020-2025)

3.1.2 Global Statin Revenue Market Share by Players (2020-2025)

3.2 Global Statin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Statin Revenue

3.4 Global Statin Market Concentration Ratio

3.4.1 Global Statin Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Statin Revenue in 2024

3.5 Global Key Players of Statin Head office and Area Served

3.6 Global Key Players of Statin, Product and Application

3.7 Global Key Players of Statin, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Statin Breakdown Data by Type

4.1 Global Statin Historic Market Size by Type (2020-2025)

4.2 Global Statin Forecasted Market Size by Type (2026-2031)

5 Statin Breakdown Data by Application

5.1 Global Statin Historic Market Size by Application (2020-2025)

5.2 Global Statin Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Statin Market Size (2020-2031)

6.2 North America Statin Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Statin Market Size by Country (2020-2025)

6.4 North America Statin Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Statin Market Size (2020-2031)

7.2 Europe Statin Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Statin Market Size by Country (2020-2025)

7.4 Europe Statin Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Statin Market Size (2020-2031)

8.2 Asia-Pacific Statin Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Statin Market Size by Region (2020-2025)

8.4 Asia-Pacific Statin Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Statin Market Size (2020-2031)

9.2 Latin America Statin Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Statin Market Size by Country (2020-2025)

9.4 Latin America Statin Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Statin Market Size (2020-2031)

10.2 Middle East & Africa Statin Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Statin Market Size by Country (2020-2025)

10.4 Middle East & Africa Statin Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Statin Introduction

11.1.4 Pfizer Revenue in Statin Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Statin Introduction

11.2.4 AstraZeneca Revenue in Statin Business (2020-2025)

11.2.5 AstraZeneca Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Statin Introduction

11.3.4 Merck Revenue in Statin Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Huizhi

11.4.1 Huizhi Company Details

11.4.2 Huizhi Business Overview

11.4.3 Huizhi Statin Introduction

11.4.4 Huizhi Revenue in Statin Business (2020-2025)

11.4.5 Huizhi Recent Development

11.5 Daiichi Sankyo

11.5.1 Daiichi Sankyo Company Details

11.5.2 Daiichi Sankyo Business Overview

11.5.3 Daiichi Sankyo Statin Introduction

11.5.4 Daiichi Sankyo Revenue in Statin Business (2020-2025)

11.5.5 Daiichi Sankyo Recent Development

11.6 LUNAN BETTER

11.6.1 LUNAN BETTER Company Details

11.6.2 LUNAN BETTER Business Overview

11.6.3 LUNAN BETTER Statin Introduction

11.6.4 LUNAN BETTER Revenue in Statin Business (2020-2025)

11.6.5 LUNAN BETTER Recent Development

11.7 CHIA TAI TIANQING

11.7.1 CHIA TAI TIANQING Company Details

11.7.2 CHIA TAI TIANQING Business Overview

11.7.3 CHIA TAI TIANQING Statin Introduction

11.7.4 CHIA TAI TIANQING Revenue in Statin Business (2020-2025)

11.7.5 CHIA TAI TIANQING Recent Development

11.8 Zhejiang Jingxin Pharmaceutical

11.8.1 Zhejiang Jingxin Pharmaceutical Company Details

11.8.2 Zhejiang Jingxin Pharmaceutical Business Overview

11.8.3 Zhejiang Jingxin Pharmaceutical Statin Introduction

11.8.4 Zhejiang Jingxin Pharmaceutical Revenue in Statin Business (2020-2025)

11.8.5 Zhejiang Jingxin Pharmaceutical Recent Development

11.9 Hanhui Pharmaceutical

11.9.1 Hanhui Pharmaceutical Company Details

11.9.2 Hanhui Pharmaceutical Business Overview

11.9.3 Hanhui Pharmaceutical Statin Introduction

11.9.4 Hanhui Pharmaceutical Revenue in Statin Business (2020-2025)

11.9.5 Hanhui Pharmaceutical Recent Development

11.10 Shanghai Shyndec Pharmaceutical

11.10.1 Shanghai Shyndec Pharmaceutical Company Details

11.10.2 Shanghai Shyndec Pharmaceutical Business Overview

11.10.3 Shanghai Shyndec Pharmaceutical Statin Introduction

11.10.4 Shanghai Shyndec Pharmaceutical Revenue in Statin Business (2020-2025)

11.10.5 Shanghai Shyndec Pharmaceutical Recent Development

11.11 Livzon Pharmaceutical

11.11.1 Livzon Pharmaceutical Company Details

11.11.2 Livzon Pharmaceutical Business Overview

11.11.3 Livzon Pharmaceutical Statin Introduction

11.11.4 Livzon Pharmaceutical Revenue in Statin Business (2020-2025)

11.11.5 Livzon Pharmaceutical Recent Development

11.12 North China Pharmaceutical

11.12.1 North China Pharmaceutical Company Details

11.12.2 North China Pharmaceutical Business Overview

11.12.3 North China Pharmaceutical Statin Introduction

11.12.4 North China Pharmaceutical Revenue in Statin Business (2020-2025)

11.12.5 North China Pharmaceutical Recent Development

11.13 Novartis

11.13.1 Novartis Company Details

11.13.2 Novartis Business Overview

11.13.3 Novartis Statin Introduction

11.13.4 Novartis Revenue in Statin Business (2020-2025)

11.13.5 Novartis Recent Development

11.14 Beijing Jialin Pharmaceutical

11.14.1 Beijing Jialin Pharmaceutical Company Details

11.14.2 Beijing Jialin Pharmaceutical Business Overview

11.14.3 Beijing Jialin Pharmaceutical Statin Introduction

11.14.4 Beijing Jialin Pharmaceutical Revenue in Statin Business (2020-2025)

11.14.5 Beijing Jialin Pharmaceutical Recent Development

11.15 Henan Topfond Pharmaceutical

11.15.1 Henan Topfond Pharmaceutical Company Details

11.15.2 Henan Topfond Pharmaceutical Business Overview

11.15.3 Henan Topfond Pharmaceutical Statin Introduction

11.15.4 Henan Topfond Pharmaceutical Revenue in Statin Business (2020-2025)

11.15.5 Henan Topfond Pharmaceutical Recent Development

11.16 China Resources Double-Crane Pharmaceutical

11.16.1 China Resources Double-Crane Pharmaceutical Company Details

11.16.2 China Resources Double-Crane Pharmaceutical Business Overview

11.16.3 China Resources Double-Crane Pharmaceutical Statin Introduction

11.16.4 China Resources Double-Crane Pharmaceutical Revenue in Statin Business (2020-2025)

11.16.5 China Resources Double-Crane Pharmaceutical Recent Development

11.17 Wanbang Biopharmaceuticals

11.17.1 Wanbang Biopharmaceuticals Company Details

11.17.2 Wanbang Biopharmaceuticals Business Overview

11.17.3 Wanbang Biopharmaceuticals Statin Introduction

11.17.4 Wanbang Biopharmaceuticals Revenue in Statin Business (2020-2025)

11.17.5 Wanbang Biopharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Merck

Pfizer Inc

Daiichi Sankyo

Chia Tai Tianqing

Zhejiang Jingxin Pharmaceutical

Hanhui Pharmaceutical

Shanghai Shyndec Pharmaceutical

Livzon Pharmaceutical

North China Pharmaceutical

Novartis

Beijing Jialin Pharmaceutical

Henan Topfond Pharmaceutical

China Resources Double Crane Pharmaceutical

Wanbang Biopharmaceuticals

Huizhi

LUNAN BETTER

List of Tables

Table 1. Global Statin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Astrovastatin

Table 3. Key Players of Rosuvastatin

Table 4. Key Players of Pitavastatin

Table 5. Key Players of Others

Table 6. Global Statin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Statin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Statin Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Statin Market Share by Region (2020-2025)

Table 10. Global Statin Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Statin Market Share by Region (2026-2031)

Table 12. Statin Market Trends

Table 13. Statin Market Drivers

Table 14. Statin Market Challenges

Table 15. Statin Market Restraints

Table 16. Global Statin Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Statin Market Share by Players (2020-2025)

Table 18. Global Top Statin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Statin as of 2024)

Table 19. Ranking of Global Top Statin Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Statin Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Statin, Headquarters and Area Served

Table 22. Global Key Players of Statin, Product and Application

Table 23. Global Key Players of Statin, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Statin Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Statin Revenue Market Share by Type (2020-2025)

Table 27. Global Statin Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Statin Revenue Market Share by Type (2026-2031)

Table 29. Global Statin Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Statin Revenue Market Share by Application (2020-2025)

Table 31. Global Statin Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Statin Revenue Market Share by Application (2026-2031)

Table 33. North America Statin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Statin Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Statin Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Statin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Statin Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Statin Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Statin Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Statin Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Statin Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Statin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Statin Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Statin Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Statin Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Statin Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Statin Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Statin Product

Table 51. Pfizer Revenue in Statin Business (2020-2025) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. AstraZeneca Company Details

Table 54. AstraZeneca Business Overview

Table 55. AstraZeneca Statin Product

Table 56. AstraZeneca Revenue in Statin Business (2020-2025) & (US$ Million)

Table 57. AstraZeneca Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Statin Product

Table 61. Merck Revenue in Statin Business (2020-2025) & (US$ Million)

Table 62. Merck Recent Development

Table 63. Huizhi Company Details

Table 64. Huizhi Business Overview

Table 65. Huizhi Statin Product

Table 66. Huizhi Revenue in Statin Business (2020-2025) & (US$ Million)

Table 67. Huizhi Recent Development

Table 68. Daiichi Sankyo Company Details

Table 69. Daiichi Sankyo Business Overview

Table 70. Daiichi Sankyo Statin Product

Table 71. Daiichi Sankyo Revenue in Statin Business (2020-2025) & (US$ Million)

Table 72. Daiichi Sankyo Recent Development

Table 73. LUNAN BETTER Company Details

Table 74. LUNAN BETTER Business Overview

Table 75. LUNAN BETTER Statin Product

Table 76. LUNAN BETTER Revenue in Statin Business (2020-2025) & (US$ Million)

Table 77. LUNAN BETTER Recent Development

Table 78. CHIA TAI TIANQING Company Details

Table 79. CHIA TAI TIANQING Business Overview

Table 80. CHIA TAI TIANQING Statin Product

Table 81. CHIA TAI TIANQING Revenue in Statin Business (2020-2025) & (US$ Million)

Table 82. CHIA TAI TIANQING Recent Development

Table 83. Zhejiang Jingxin Pharmaceutical Company Details

Table 84. Zhejiang Jingxin Pharmaceutical Business Overview

Table 85. Zhejiang Jingxin Pharmaceutical Statin Product

Table 86. Zhejiang Jingxin Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 87. Zhejiang Jingxin Pharmaceutical Recent Development

Table 88. Hanhui Pharmaceutical Company Details

Table 89. Hanhui Pharmaceutical Business Overview

Table 90. Hanhui Pharmaceutical Statin Product

Table 91. Hanhui Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 92. Hanhui Pharmaceutical Recent Development

Table 93. Shanghai Shyndec Pharmaceutical Company Details

Table 94. Shanghai Shyndec Pharmaceutical Business Overview

Table 95. Shanghai Shyndec Pharmaceutical Statin Product

Table 96. Shanghai Shyndec Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 97. Shanghai Shyndec Pharmaceutical Recent Development

Table 98. Livzon Pharmaceutical Company Details

Table 99. Livzon Pharmaceutical Business Overview

Table 100. Livzon Pharmaceutical Statin Product

Table 101. Livzon Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 102. Livzon Pharmaceutical Recent Development

Table 103. North China Pharmaceutical Company Details

Table 104. North China Pharmaceutical Business Overview

Table 105. North China Pharmaceutical Statin Product

Table 106. North China Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 107. North China Pharmaceutical Recent Development

Table 108. Novartis Company Details

Table 109. Novartis Business Overview

Table 110. Novartis Statin Product

Table 111. Novartis Revenue in Statin Business (2020-2025) & (US$ Million)

Table 112. Novartis Recent Development

Table 113. Beijing Jialin Pharmaceutical Company Details

Table 114. Beijing Jialin Pharmaceutical Business Overview

Table 115. Beijing Jialin Pharmaceutical Statin Product

Table 116. Beijing Jialin Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 117. Beijing Jialin Pharmaceutical Recent Development

Table 118. Henan Topfond Pharmaceutical Company Details

Table 119. Henan Topfond Pharmaceutical Business Overview

Table 120. Henan Topfond Pharmaceutical Statin Product

Table 121. Henan Topfond Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 122. Henan Topfond Pharmaceutical Recent Development

Table 123. China Resources Double-Crane Pharmaceutical Company Details

Table 124. China Resources Double-Crane Pharmaceutical Business Overview

Table 125. China Resources Double-Crane Pharmaceutical Statin Product

Table 126. China Resources Double-Crane Pharmaceutical Revenue in Statin Business (2020-2025) & (US$ Million)

Table 127. China Resources Double-Crane Pharmaceutical Recent Development

Table 128. Wanbang Biopharmaceuticals Company Details

Table 129. Wanbang Biopharmaceuticals Business Overview

Table 130. Wanbang Biopharmaceuticals Statin Product

Table 131. Wanbang Biopharmaceuticals Revenue in Statin Business (2020-2025) & (US$ Million)

Table 132. Wanbang Biopharmaceuticals Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Statin Picture

Figure 2. Global Statin Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Statin Market Share by Type: 2024 VS 2031

Figure 4. Astrovastatin Features

Figure 5. Rosuvastatin Features

Figure 6. Pitavastatin Features

Figure 7. Others Features

Figure 8. Global Statin Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Statin Market Share by Application: 2024 VS 2031

Figure 10. Cardiovascular Disorders Case Studies

Figure 11. Obesity Case Studies

Figure 12. Inflammatory Disorders Case Studies

Figure 13. Others Case Studies

Figure 14. Statin Report Years Considered

Figure 15. Global Statin Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Statin Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Statin Market Share by Region: 2024 VS 2031

Figure 18. Global Statin Market Share by Players in 2024

Figure 19. Global Top Statin Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Statin as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Statin Revenue in 2024

Figure 21. North America Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Statin Market Share by Country (2020-2031)

Figure 23. United States Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Statin Market Share by Country (2020-2031)

Figure 27. Germany Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Statin Market Share by Region (2020-2031)

Figure 35. China Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Statin Market Share by Country (2020-2031)

Figure 43. Mexico Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Statin Market Share by Country (2020-2031)

Figure 47. Turkey Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Statin Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Statin Business (2020-2025)

Figure 51. AstraZeneca Revenue Growth Rate in Statin Business (2020-2025)

Figure 52. Merck Revenue Growth Rate in Statin Business (2020-2025)

Figure 53. Huizhi Revenue Growth Rate in Statin Business (2020-2025)

Figure 54. Daiichi Sankyo Revenue Growth Rate in Statin Business (2020-2025)

Figure 55. LUNAN BETTER Revenue Growth Rate in Statin Business (2020-2025)

Figure 56. CHIA TAI TIANQING Revenue Growth Rate in Statin Business (2020-2025)

Figure 57. Zhejiang Jingxin Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 58. Hanhui Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 59. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 60. Livzon Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 61. North China Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 62. Novartis Revenue Growth Rate in Statin Business (2020-2025)

Figure 63. Beijing Jialin Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 64. Henan Topfond Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 65. China Resources Double-Crane Pharmaceutical Revenue Growth Rate in Statin Business (2020-2025)

Figure 66. Wanbang Biopharmaceuticals Revenue Growth Rate in Statin Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Mevastatin Market Research Report 2025

Global Rosuvastatin Market Research Report 2025

Cholesterol Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rosuvastatin Drugs Market Research Report 2024

Lovastatin Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dyslipidemia Therapeutics Market Research Report 2024

Hypolipidemic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti hyperlipidemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cholesterol lowering Statins Market Research Report 2024

Global Ezetimibe Simvastatin Tablets Market Research Report 2024

Chemical Lipid Lowering Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperlipidemia Drugs Market Research Report 2024

Global Simvastatin API Market Research Report 2025

Global Cholesterol Testing Products Market Research Report 2024

Global Low Density Lipoprotein LDL Test Market Research Report 2024

Global Cholesterol Lowering Drugs Market Research Report 2024

Pharmaceuticals Lipids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rosuvastatin Methyl Ester Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions